Internal Medicine · Danville, PA
NPI
1891149126
Since 2016
Specialty
Internal Medicine
Code 207R00000X
Group practices
11
Medicare group memberships
Hospitals
5
Hospital affiliations
100 N Academy Ave
Danville, PA, 17822
Phone (570) 271-6045
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
553 services
Medicare patients, 2024
154
Average age 77
Drug cost, 2024
$5.6M
1,015 prescriptions
Company payments, 2025
$60K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Evan Wu was code 99214 (office e&m - established), 238 times for 76 patients. In total Evan Wu billed 553 services in 8 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 238 | 76 | $95.40 | $23K |
| 99214 Office E&M - Established | Facility | 206 | 64 | $70.82 | $15K |
| 99215 Office E&M - Established | Facility | 28 | 18 | $114.31 | $3,201 |
| 99215 Office E&M - Established | Office | 21 | 11 | $147.91 | $3,106 |
| 99205 Office E&M - New | Office | 18 | 18 | $179.67 | $3,234 |
| 99205 Office E&M - New | Facility | 14 | 14 | $143.26 | $2,006 |
By year: 2022 $53K for 487 services; 2023 $40K for 411 services; 2024 $51K for 553 services.
Medicare prescription drug claims, 2024
In 2024, the drug Evan Wu prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 229 prescriptions and refills. In total Evan Wu wrote 1,015 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 229 | 233 | 32 | $3.9M |
| Ondansetron Hcl Generic | 74 | 74 | 62 | $1,371 |
| Prochlorperazine Maleate Generic | 70 | 70 | 57 | $891 |
| Dexamethasone Generic | 68 | 84 | 56 | $3,000 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 35 | 35 | 32 | $381 |
| Folic Acid Generic | 28 | 83 | 16 | $254 |
| Furosemide Generic | 23 | 39 | 13 | $106 |
| Gabapentin Generic | 23 | 43 | 12 | $374 |
| Levothyroxine Sodium Generic | 22 | 62 | Under 11 | $202 |
| Lenvima Lenvatinib Mesylate | 21 | 21 | Under 11 | $511K |
| Betamethasone Dipropionate Generic | 20 | 21 | 14 | $850 |
| Alecensa Alectinib Hcl | 19 | 27 | Under 11 | $339K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 19 | 19 | 13 | $207 |
| Oxycodone Hcl Generic | 19 | 19 | 14 | $300 |
| Eliquis Apixaban | 18 | 24 | Under 11 | $14K |
Brand drugs: 395 claims; generic drugs: 620 claims; opioid claims: 61.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Evan Wu $60K ($60K in general payments such as food, travel and fees) from 15 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $27K.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $27K |
| Jazz Pharmaceuticals Inc. JAZZ | 9 | $13K |
| Janssen Biotech, Inc. JNJ | 5 | $9,152 |
| Amgen Inc. AMGN | 1 | $4,116 |
| SpringWorks Therapeutics, Inc. | 2 | $2,040 |
| Fosun Pharma USA Inc. | 1 | $1,750 |
| Genentech USA, Inc. ROG.SW | 1 | $1,070 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $985 |
| Daiichi Sankyo Inc. 4568.T | 3 | $564 |
| Gilead Sciences, Inc. GILD | 1 | $67.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.